MAPT and Parkinson disease: Early genome-wide association studies (GWAS) confirmed associations at the SNCA and MAPT loci, and highlighted novel associations at LRRK2 and PARK16 loci as risk factors for PD in both European and Japanese clinical cohorts [85, 86].